Back
ESC Premium Access

Closing remarks - Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease.

Session: Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease
Topic: Diabetes, dysglycaemia and metabolic syndrome
Speaker: Professor D. McGuire (Dallas, US)
Sponsored by MSD
Event: ESC Congress 2017

Congress Presentation

Add to my library

Like

About the speaker

Professor Darren Keith McGuire

University of Texas Southwestern Medical Center, Dallas (United States of America)
21 presentations
0 follower

6 more presentations in this session

Opening remarks - Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease.

Speaker: Professor S. Del Prato (Pisa, IT)

Access
Like
Thumbnail

Why control glycemia?

Speaker: Professor L. Leiter (Toronto, CA)

Access
Like
Thumbnail

Clarifying the role for DPP-4 inhibitors in the treatment of patients with type 2 diabetes at risk of heart failure.

Speaker: Professor D. McGuire (Dallas, US)

Access
Like
Thumbnail

DPP-4 inhibitors and SGLT2 inhibitors - A mechanism for the future?

Speaker: Associate Professor D. Cherney (Toronto, CA)

Access
Like
Thumbnail

Q&A - Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease.

Speaker: Professor S. Del Prato (Pisa, IT)

Access
Like
Thumbnail

Access the full session

Considerations for cardiologists: further insights into treatment options for patients with type 2 diabetes and cardiovascular disease

Speakers: Professor D. McGuire, Professor S. Del Prato, Professor L. Leiter, Professor D. McGuire, Associate Professor D. Cherney...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2017

26 August - 30 August 2017

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources